| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.9 |